Cargando…

Genetic and molecular mechanisms in multiple myeloma: a route to better understand disease pathogenesis and heterogeneity

Multiple myeloma (MM) is a heterogeneous plasma cell neoplasm presenting with a wide range of clinical manifestations. In spite of the availability of very performing treatment modalities, survival is highly varying, ranging from a few months to several years. Underlying genetic and microenvironment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kyrtsonis, Marie-Christine, Bartzis, Vassiliki, Papanikolaou, Xenophon, Koulieris, Efstathios, Georgiou, George, Dimou, Maria, Tzenou, Tatiana, Panayiotidis, Panayiotis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681163/ https://www.ncbi.nlm.nih.gov/pubmed/23776351

Ejemplares similares

Ratio of involved/uninvolved immunoglobulin quantification by Hevylite™ assay: clinical and prognostic impact in multiple myeloma
por: Koulieris, Efstathios, et al.
Publicado: (2012)

Serum Soluble TACI, a BLyS Receptor, Is a Powerful Prognostic Marker of Outcome in Chronic Lymphocytic Leukemia
por: Kyrtsonis, Marie-Christine, et al.
Publicado: (2014)

Prognostic Significance of Serum Free Light Chains in Chronic Lymphocytic Leukemia
por: Sarris, Katerina, et al.
Publicado: (2013)

Clonotypic Analysis of Immunoglobulin Heavy Chain Sequences in Patients with Waldenström's Macroglobulinemia: Correlation with MYD88 L265P Somatic Mutation Status, Clinical Features, and Outcome
por: Petrikkos, Loizos, et al.
Publicado: (2014)

Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time‐limited venetoclax/obinutuzumab treatment
por: Dimou, Maria, et al.
Publicado: (2021)

New Insights into Malignant B-Cell Disorders
por: Kyrtsonis, Marie-Christine, et al.
Publicado: (2015)

New Insights into Monoclonal B-Cell Lymphocytosis
por: Kalpadakis, Christina, et al.
Publicado: (2014)

Serum Procalcitonin Levels in Newly Diagnosed Hodgkin Lymphoma: Correlation with Other Inflammatory Biomarkers
por: Piperidou, Alexia, et al.
Publicado: (2022)

P051: Serum procalcitonin levels in newly diagnosed classical Hodgkin Lymphoma (cHL): Correlation with other inflammatory biomarkers
por: Piperidou, Alexia, et al.
Publicado: (2022)

Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood‐brain barrier be a disease “sanctuary” during venetoclax treatment?
por: Dimou, Maria, et al.
Publicado: (2021)

The Clinical and Prognostic Significance of Ribonucleotide Reductase Subunits RRM1 and RRM2 mRNA Levels in Patients with Chronic Lymphocytic Leukemia
por: Chatzidavid, Sevastianos, et al.
Publicado: (2023)

Snake Antivenoms—Toward Better Understanding of the Administration Route
por: Gamulin, Erika, et al.
Publicado: (2023)

The role of magnetic resonance imaging in the evaluation of transfusional iron overload in myelodysplastic syndromes
por: Petrou, Emmanouil, et al.
Publicado: (2015)

Tyrosine Kinase Inhibitors and Interferon
por: Dimou, Maria, et al.
Publicado: (2014)

Carfilzomib Improves Bone Metabolism in Patients with Advanced Relapsed/Refractory Multiple Myeloma: Results of the CarMMa Study
por: Terpos, Evangelos, et al.
Publicado: (2021)

Extracellular Vesicles in Multiple Myeloma—Cracking the Code to a Better Understanding of the Disease
por: Iskrzak, Justyna, et al.
Publicado: (2022)

Towards Better Understanding of the Pathogenesis of Neuronal Respiratory Network in Sudden Perinatal Death
por: Mehboob, Riffat, et al.
Publicado: (2017)

Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis
por: Yan, Lijun, et al.
Publicado: (2019)

Does patenting always help new firm survival? Understanding heterogeneity among exit routes
por: Kato, Masatoshi, et al.
Publicado: (2021)

The molecular pathogenesis of multiple myeloma
por: Bolli, Niccolò, et al.
Publicado: (2020)

Pathogenesis and treatment of multiple myeloma
por: Yang, Peipei, et al.
Publicado: (2022)

Single cell and immunity: Better understanding immune cell heterogeneities with single cell sequencing
por: Chen, Dongsheng, et al.
Publicado: (2022)

Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma
por: Jakubikova, Jana, et al.
Publicado: (2023)

Implications of Heterogeneity in Multiple Myeloma
por: de Mel, Sanjay, et al.
Publicado: (2014)

Non-Small Cell Lung Cancer beyond Biomarkers: The Evolving Landscape of Clinical Trial Design
por: Dimou, Anastasios, et al.
Publicado: (2014)

Gene prioritization, communality analysis, networking and metabolic integrated pathway to better understand breast cancer pathogenesis
por: López-Cortés, Andrés, et al.
Publicado: (2018)

Evaluation of cytogenetic damage in exfoliated nasal epithelial cells contributes to a better understanding of the pathogenesis of rhinosinusitis()
por: Souza, Ana Carolina Flygare, et al.
Publicado: (2019)

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival
por: Katodritou, Eirini, et al.
Publicado: (2018)

Vaccine hesitancy: understanding better to address better
por: Kumar, Dewesh, et al.
Publicado: (2016)

Routes to cubic ice through heterogeneous nucleation
por: Davies, Michael Benedict, et al.
Publicado: (2021)

TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece
por: Kakkas, Ioannis, et al.
Publicado: (2021)

Multiple Myeloma: Heterogeneous in Every Way
por: Schavgoulidze, Anaïs, et al.
Publicado: (2021)

Pathogenesis and heterogeneity of ovarian cancer
por: Kroeger, Paul T., et al.
Publicado: (2017)

PB2140: EVALUATION OF EARLY RELAPSE IN MULTIPLE MYELOMA (MM) PATIENTS
por: Gkioka, Annita-Ioanna, et al.
Publicado: (2023)

Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents
por: Teramachi, Jumpei, et al.
Publicado: (2023)

Therapy-Related Myeloid Malignancies in Myeloma
por: Papanikolaou, X., et al.
Publicado: (2011)

Genetic interaction networks: better understand to better predict
por: Boucher, Benjamin, et al.
Publicado: (2013)

Better understanding of ICI-induced cholangitis for better management
por: Meunier, Lucy, et al.
Publicado: (2023)

Pathogenesis and treatment of multiple myeloma bone disease
por: Hiasa, Masahiro, et al.
Publicado: (2021)

Involvement of Alarmins in the Pathogenesis and Progression of Multiple Myeloma
por: Murdaca, Giuseppe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ond5jd65ajf9c4lpti5sm7ooqk